Cleveland BioLabs Operating Income

Cleveland BioLabs (CBLI) currently reports a operating income of $-2.8M as of June 2021. That compares with $-1.8M in the prior-year period — down 50.9% year over year. Use the charts on this page to explore Cleveland BioLabs's operating income history and peer comparisons.

Cleveland BioLabs's operating income decreased from $-1.8M to $-2.8M — a 50.9% year-over-year decrease (period ending June 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cleveland BioLabs reported $-2.8M in operating income as of June 2021. That compares with $-1.8M in the prior-year period — down 50.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-2.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cleveland BioLabs, and consider following CBLI for alerts when major investors trade the stock.

Cleveland BioLabs is classified in the Healthcare sector. On operating income, it currently shows $-2.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CBLI with unrelated industries.